Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Chubb
Mallinckrodt
UBS
Queensland Health
Teva
Fish and Richardson
QuintilesIMS
Covington
Cerilliant

Generated: January 19, 2018

DrugPatentWatch Database Preview

LEVOXYL Drug Profile

« Back to Dashboard

Which patents cover Levoxyl, and when can generic versions of Levoxyl launch?

Levoxyl is a drug marketed by King Pharms and is included in one NDA. There are three patents protecting this drug.

This drug has twenty-six patent family members in nine countries.

The generic ingredient in LEVOXYL is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
Drug patent expirations by year for LEVOXYL
Pharmacology for LEVOXYL
Ingredient-typeThyroxine
Drug Classl-Thyroxine

US Patents and Regulatory Information for LEVOXYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-011 May 25, 2001 AB1,AB3 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-010 May 25, 2001 AB1,AB3 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-011 May 25, 2001 AB1,AB3 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-010 May 25, 2001 AB1,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-001 May 25, 2001 AB1,AB3 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-006 May 25, 2001 AB1,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-008 May 25, 2001 AB1,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-003 May 25, 2001 AB1,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-012 May 25, 2001 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-002 May 25, 2001 AB1,AB3 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for LEVOXYL

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Novartis
Healthtrust
Express Scripts
McKesson
Cantor Fitzgerald
Queensland Health
Cerilliant
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot